{
    "clinical_study": {
        "@rank": "144489", 
        "arm_group": {
            "arm_group_label": "UT-15C", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers"
        }, 
        "brief_title": "Three Times Daily Dosing of UT-15C", 
        "completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "-  Healthy male and female subjects\n\n          -  aged 18-55 years of age;\n\n          -  weight between 50 and 100 kg, with a body mass index (BMI) between 19.0 and 29.9\n             kg/m2, inclusive for female subjects and\n\n          -  weight between 50 and 120 kg, with a BMI between 19.0 and 32.0 kg/m\u00b2, inclusive for\n             male subjects."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01746485", 
            "org_study_id": "TDE-DU-102"
        }, 
        "intervention": {
            "arm_group_label": "UT-15C", 
            "intervention_name": "UT-15C", 
            "intervention_type": "Drug", 
            "other_name": [
                "treprostinil diethanolamine", 
                "treprostinil diolamine", 
                "UT-15C SR"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Treprostinil"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Volunteers", 
        "lastchanged_date": "December 10, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Austin", 
                    "country": "United States", 
                    "state": "Texas"
                }, 
                "name": "PPD Development"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects", 
        "overall_official": {
            "affiliation": "PPD", 
            "last_name": "Theresa Pham, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Cmax, tmax, AUC(0-6), AUC(0-24), AUC(6-12), AUC(12-24) and t1/2", 
            "measure": "Area under the curve (AUC) from 0-24hrs after 6 days of TID dosing.", 
            "safety_issue": "No", 
            "time_frame": "6 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01746485"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Day 1: Cmax, tmax, AUC(0-6), AUC(0-24), AUC(0-t), AUC(0-inf), and t1/2", 
            "measure": "PK profile of UT-15C after a single 0.5mg dose on Day 1", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "United Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "United Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}